ERAP1 and autoimmune disease: We observed no significantly altered burden of functionally impactful variation across these groups for ERAP1 (CD vs CD and ≥ 1 autoimmune disease diagnosis p = 0.376, UC vs UC and ≥ 1 autoimmune disease diagnosis p = 0.369).